HFMA provides comments to Senators to inform the bipartisan initiative to increase healthcare price and quality transparency, as described in a February 28, 2018, letter.
HFMA Comments on the Senate Transparency Initiative
The Healthcare Financial Management Association (HFMA) would like to thank you for the opportunity to provide comments to inform the bipartisan initiative to increase healthcare price and quality transparency, as described in your letter of February 28, 2018.
In 2014, HFMA convened a multi-stakeholder task force charged with reaching consensus on how consumers can obtain clear and easy-to-understand healthcare price and quality information in a timely fashion. The recommendations that emerged from this task force were published in Price Transparency in Health Care: Report from the HFMA Price Transparency Task Force . The comments submitted here are grounded in the industry-consensus recommendations found in that report, along with the Patient Financial Communications Best Practices , which were developed with the guidance of a multi-stakeholder steering committee convened by HFMA.
The questions posed in your letter of February 28 are reprinted below, followed by HFMA’s responses.